BioLargo Past Earnings Performance

Past criteria checks 0/6

BioLargo has been growing earnings at an average annual rate of 28%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 49.7% per year.

Key information

28.0%

Earnings growth rate

41.7%

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate49.7%
Return on equity-60.8%
Net Margin-11.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BioLargo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:BLGO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2418-293
30 Jun 2417-393
31 Mar 2413-493
31 Dec 2312-482
30 Sep 2310-482
30 Jun 239-372
31 Mar 239-371
31 Dec 226-471
30 Sep 225-661
30 Jun 224-761
31 Mar 223-761
31 Dec 213-761
30 Sep 213-671
30 Jun 213-771
31 Mar 213-881
31 Dec 202-871
30 Sep 202-971
30 Jun 202-1171
31 Mar 202-1061
31 Dec 192-1161
30 Sep 192-1061
30 Jun 192-962
31 Mar 191-1062
31 Dec 181-1052
30 Sep 181-1052
30 Jun 181-1052
31 Mar 181-952
31 Dec 171-942
30 Sep 170-941
30 Jun 170-941
31 Mar 170-941
31 Dec 160-841
30 Sep 160-741
30 Jun 160-641
31 Mar 160-641
31 Dec 150-541
30 Sep 150-531
30 Jun 150-431
31 Mar 150-331
31 Dec 140-431
30 Sep 140-431
30 Jun 140-331
31 Mar 140-321
31 Dec 130-321

Quality Earnings: BLGO is currently unprofitable.

Growing Profit Margin: BLGO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BLGO is unprofitable, but has reduced losses over the past 5 years at a rate of 28% per year.

Accelerating Growth: Unable to compare BLGO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BLGO is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (4.8%).


Return on Equity

High ROE: BLGO has a negative Return on Equity (-60.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioLargo, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard RyanOak Ridge Financial Services Group Inc.